What is the significance of the pharmacokinetic profile and potential drug-drug interactions of long-acting intramuscular cabotegravir and rilpivirine?

Bettonte, Sara; Berton, Mattia; Marzolini, Catia

Bettonte, Sara; Berton, Mattia; Marzolini, Catia.

Affiliation

Bettonte S; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital, Basel, Switzerland.
Berton M; Faculty of Medicine, University of Basel, Basel, Switzerland.
Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital, Basel, Switzerland.

Expert Opin Drug Metab Toxicol ; 19(5): 243-247, 2023.

Article de En | MEDLINE | ID: mdl-37293864

Sujet(s)
Mots clés

Long-acting; cabotegravir; drug-drug interactions; intramuscular; rilpivirine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / Agents antiVIH Limites: Humans Langue: En Journal: Expert Opin Drug Metab Toxicol Sujet du journal: METABOLISMO / TOXICOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google